Turnstone Biologics Corp. Earnings Per Share (Diluted)
Turnstone Biologics Corp. reported Earnings Per Share (Diluted) of -$0.24 per share for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-08-08.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2025-08-08
- Turnstone Biologics Corp. earnings per share, diluted for the quarter ending 2025-06-30 was -$0.24.
- Turnstone Biologics Corp. earnings per share, diluted for the quarter ending 2025-03-31 was -$0.51.
- Turnstone Biologics Corp. earnings per share, diluted for the quarter ending 2024-12-31 was -$0.56.
- Turnstone Biologics Corp. earnings per share, diluted for the quarter ending 2024-09-30 was -$0.74.
- Turnstone Biologics Corp. earnings per share, diluted for fiscal 2024 was -$3.07.
- Turnstone Biologics Corp. earnings per share, diluted for fiscal 2023 was -$4.78.
- Turnstone Biologics Corp. earnings per share, diluted for fiscal 2022 was -$12.49.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2025-06-30 | -$0.24 10-Q · filed 2025-08-08 | -$0.75 10-Q · filed 2025-08-08 | ||
| 2025-03-31 | -$0.51 10-Q · filed 2025-05-09 | |||
| 2024-12-31 | -$0.56 derived: net income ÷ weighted average shares · filed 2025-03-31 | -$1.30 derived: net income ÷ weighted average shares · filed 2025-03-31 | -$2.22 derived: net income ÷ weighted average shares · filed 2025-08-08 | -$3.07 10-K · filed 2025-03-31 |
| 2024-09-30 | -$0.74 10-Q · filed 2024-11-12 | -$1.66 derived: net income ÷ weighted average shares · filed 2025-08-08 | -$2.52 10-Q · filed 2024-11-12 | -$3.23 derived: net income ÷ weighted average shares · filed 2025-08-08 |
| 2024-06-30 | -$0.92 10-Q · filed 2025-08-08 | -$1.78 10-Q · filed 2025-08-08 | -$2.49 derived: net income ÷ weighted average shares · filed 2025-08-08 | -$3.45 derived: net income ÷ weighted average shares · filed 2025-08-08 |
| 2024-03-31 | -$0.85 10-Q · filed 2025-05-09 | -$1.57 derived: net income ÷ weighted average shares · filed 2025-05-09 | -$2.52 derived: net income ÷ weighted average shares · filed 2025-05-09 | -$4.52 derived: net income ÷ weighted average shares · filed 2025-05-09 |
| 2023-12-31 | -$0.71 derived: net income ÷ weighted average shares · filed 2025-03-31 | -$1.67 derived: net income ÷ weighted average shares · filed 2025-03-31 | -$3.83 derived: net income ÷ weighted average shares · filed 2025-03-31 | -$4.78 10-K · filed 2025-03-31 |
| 2023-09-30 | -$1.00 10-Q · filed 2024-11-12 | -$3.84 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$5.02 10-Q · filed 2024-11-12 | |
| 2023-06-30 | -$7.56 10-Q · filed 2024-08-14 | -$7.62 10-Q · filed 2024-08-14 | ||
| 2022-12-31 | -$5.13 derived: net income ÷ weighted average shares · filed 2024-03-22 | -$11.28 derived: net income ÷ weighted average shares · filed 2024-03-22 | -$10.60 derived: net income ÷ weighted average shares · filed 2024-03-22 | -$12.49 10-K · filed 2024-03-22 |
| 2022-09-30 | -$6.15 10-Q · filed 2023-11-13 | -$5.50 derived: net income ÷ weighted average shares · filed 2023-11-13 | -$7.15 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $0.42 10-Q · filed 2023-09-01 | -$0.49 10-Q · filed 2023-09-01 |